Anticoagulant therapy of thromboembolic disease during pregnancy.
作者信息
Wehrmacher W H, Karlman R L, Scanlon P, Messmore H L
机构信息
Department of Physiology, Loyola University Chicago, Stritch School of Medicine, Maywood, IL 60153, USA.
出版信息
Compr Ther. 1998 Jun-Jul;24(6-7):289-94.
PMID:9669092
Abstract
There is growing interest in low molecular weight heparin for the management of thromboembolic disease in pregnancy. Greater understanding of the risk of thromboembolic disease versus the risk of various management practices is urgently needed to reduce maternal mortality and embryopathy in the fetus.
摘要
Zotero 插件